The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.

Megan Forliti

Mayo Clinic Contributor

Regular contributor to Mayo Clinic Magazine.

Visit website: https://advancingthescience.mayo.edu/member/mforliti/

Details last updated 08-Jul-2019

Articles written by Megan Forliti

The first senolytic drugs to target senescent cells

The first senolytic drugs to target senescent cells

Mayo Clinic - 05-Sep-2017

New platform will help to identify additional drugs that target ageing processes more quickly

CD38 enzyme: the culprit behind age related metabolic diseases

CD38 enzyme: the culprit behind age related metabolic diseases

Mayo Clinic - 14-Jun-2016

The focus is to find ways to keep up the NAD levels in tissues with ageing